USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	052284/0113			Pages:	8
		Recorded:	04/01/2020
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 15

Patent #:	9434935	Issue Dt:	09/06/2016	Application #:	13792135	Filing Dt:	03/10/2013
Publication #:	US20140255360	Pub Dt:	09/11/2014
Title:	MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF

Patent #:	9944690	Issue Dt:	04/17/2018	Application #:	14210034	Filing Dt:	03/13/2014
Publication #:	US20140286987	Pub Dt:	09/25/2014
Title:	METHODS FOR CONTROLLING T CELL PROLIFERATION

Patent #:	9913882	Issue Dt:	03/13/2018	Application #:	14296404	Filing Dt:	06/04/2014
Publication #:	US20160151465	Pub Dt:	06/02/2016
Title:	METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES

Patent #:	10934346	Issue Dt:	03/02/2021	Application #:	14622018	Filing Dt:	02/13/2015
Publication #:	US20160046700	Pub Dt:	02/18/2016
Title:	MODIFIED T CELL COMPRISING A POLYNUCLEOTIDE ENCODING AN INDUCIBLE STIMULATING MOLECULE COMPRISING MyD88, CD40 AND FKBP12

Patent #:	10888608	Issue Dt:	01/12/2021	Application #:	14842710	Filing Dt:	09/01/2015
Publication #:	US20160058857	Pub Dt:	03/03/2016
Title:	COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES

Patent #:	NONE	Issue Dt:		Application #:	14968737	Filing Dt:	12/14/2015
Publication #:	US20160166613	Pub Dt:	06/16/2016
Title:	METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS

Patent #:	NONE	Issue Dt:		Application #:	14968853	Filing Dt:	12/14/2015
Publication #:	US20160175359	Pub Dt:	06/23/2016
Title:	METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS

Patent #:	9932572	Issue Dt:	04/03/2018	Application #:	15224441	Filing Dt:	07/29/2016
Publication #:	US20170015987	Pub Dt:	01/19/2017
Title:	MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	15377776	Filing Dt:	12/13/2016
Publication #:	US20170166877	Pub Dt:	06/15/2017
Title:	DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

Patent #:	10525110	Issue Dt:	01/07/2020	Application #:	15888948	Filing Dt:	02/05/2018
Publication #:	US20180243384	Pub Dt:	08/30/2018
Title:	METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES

Patent #:	NONE	Issue Dt:		Application #:	15901556	Filing Dt:	02/21/2018
Publication #:	US20180251746	Pub Dt:	09/06/2018
Title:	MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	15910380	Filing Dt:	03/02/2018
Publication #:	US20180265566	Pub Dt:	09/20/2018
Title:	METHODS FOR CONTROLLING T CELL PROLIFERATION

Patent #:	NONE	Issue Dt:		Application #:	16611772	Filing Dt:	11/07/2019
Publication #:	US20210147507	Pub Dt:	05/20/2021
Title:	METHODS TO AUGMENT OR ALTER SIGNAL TRANSDUCTION

Patent #:	11839647	Issue Dt:	12/12/2023	Application #:	16734104	Filing Dt:	01/03/2020
Publication #:	US20200230216	Pub Dt:	07/23/2020
Title:	METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES

Patent #:	10918705	Issue Dt:	02/16/2021	Application #:	16788062	Filing Dt:	02/11/2020
Publication #:	US20200237886	Pub Dt:	07/30/2020
Title:	COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES

Assignor

Exec Dt:

03/31/2020

Assignee

133 NORTH FAIRFAX STREET

ALEXANDRIA, VIRGINIA 22314

Correspondence name and address
	DLA PIPER LLP (US)
	401 B STREET, SUITE 1700
	SAN DIEGO, CA 92101

Search Results as of: 05/24/2024 06:00 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6